Sarah B Joseph - JoVE Visualize

Showing results (41-50 of 43) with videos related to

Pageof 5

Sort By:

You have reached the last page of results.This site can display upto 43 results.

The Journal of Infectious Diseases|September 25, 2021

Stable Latent HIV Infection and Low-level Viremia Despite Treatment With the Broadly Neutralizing Antibody VRC07-523LS and the Latency Reversal Agent VorinostatCynthia L Gay, Katherine S James, Marina Tuyishime, et al.

The Journal of Clinical Investigation|June 15, 2023

Brain microglia serve as a persistent HIV reservoir despite durable antiretroviral therapyYuyang Tang, Antoine Chaillon, Sara Gianella, et al.

Journal of Virology|April 26, 2013

Comparison of viral Env proteins from acute and chronic infections with subtype C human immunodeficiency virus type 1 identifies differences in glycosylation and CCR5 utilization and suggests a new strategy for immunogen designLi-Hua Ping, Sarah B Joseph, Jeffrey A Anderson, et al.

Pageof 5

Showing results (41-50 of 43) with videos related to

Sort By:

Pageof 5

You have reached the last page of results.This site can display upto 43 results.

The Journal of Infectious Diseases|September 25, 2021

Stable Latent HIV Infection and Low-level Viremia Despite Treatment With the Broadly Neutralizing Antibody VRC07-523LS and the Latency Reversal Agent VorinostatCynthia L Gay, Katherine S James, Marina Tuyishime, et al.

The Journal of Clinical Investigation|June 15, 2023

Brain microglia serve as a persistent HIV reservoir despite durable antiretroviral therapyYuyang Tang, Antoine Chaillon, Sara Gianella, et al.

Journal of Virology|April 26, 2013

Comparison of viral Env proteins from acute and chronic infections with subtype C human immunodeficiency virus type 1 identifies differences in glycosylation and CCR5 utilization and suggests a new strategy for immunogen designLi-Hua Ping, Sarah B Joseph, Jeffrey A Anderson, et al.

Pageof 5